We’re here to close the gap between clinical need and clinical access.

While millions live with treatment-resistant depression, PTSD, or suicidality, the system remains slow to change. We believe better use of known science can offer patients a faster path forward.

WHY WE EXIST

The System Isn’t Built for Speed

Too many therapies take years to reach the people who need them most. We repurpose proven compounds, pair them with targeted delivery, and build pathways that work in real-world settings.


Because innovation should improve lives now
— not one day.

OUR APPROACH

  • Science-led: Backed by evidence, not trends.
  • Purpose-built: Designed for clinical practice, not clinical theory.
  • Locally delivered: Manufactured and packaged entirely in Australia under TGA-compliant conditions.

WHO ARE WE?

Trexapharm is a new kind of pharmaceutical company: lean, grounded, and focused on solutions that work today

  • Based in Australia with local manufacturing partnerships
  • Committed to regulatory integrity and clinical collaboration
  • Backed by a team experienced in real-world delivery and system navigation

In Australia over
1 Million people live with depression.

We intend to make a difference.

WHERE TO NEXT?

Explore information tailored to your needs — whether you’re a clinician, patient, or investor.

For Healthcare Professionals

>>

Clinical use, mechanisms, evidence, prescribing guidance

For Patients & Families

>>

What TREXAVIVE is, how it works, where to ask

For Veterans & Advocates

>>

Eligibility, DVA access, peer networks

Ours is Science that moves people forward.

For Investors

>>

Opportunity, science, momentum

Our Pipeline & Platform

>>

Beyond TREXAVIVE — our development strategy

Contact Trexapharm

>>

General, partnerships, media